908 Devices Inc (MASS) - Total Liabilities
Based on the latest financial reports, 908 Devices Inc (MASS) has total liabilities worth $52.52 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
908 Devices Inc - Total Liabilities Trend (2018–2025)
This chart illustrates how 908 Devices Inc's total liabilities have evolved over time, based on quarterly financial data. See MASS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
908 Devices Inc Competitors by Total Liabilities
The table below lists competitors of 908 Devices Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
M1 Kliniken AG
XETRA:M12
|
Germany | €56.26 Million |
|
NACCO Industries Inc
NYSE:NC
|
USA | $248.54 Million |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
India | Rs1.53 Billion |
|
P-Duke Technology Co Ltd
TWO:8109
|
Taiwan | NT$836.87 Million |
|
Amplitude Surgical SAS
PA:AMPLI
|
France | €184.97 Million |
|
Compucase Enterprise Co Ltd
TW:3032
|
Taiwan | NT$14.44 Billion |
|
Shandong Sinoglory Health
SHG:603182
|
China | CN¥260.09 Million |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$1.88 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down 908 Devices Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of 908 Devices Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how 908 Devices Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for 908 Devices Inc (2018–2025)
The table below shows the annual total liabilities of 908 Devices Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $46.37 Million | +3.32% |
| 2024-12-31 | $44.88 Million | +19.72% |
| 2023-12-31 | $37.49 Million | -27.89% |
| 2022-12-31 | $51.99 Million | +12.28% |
| 2021-12-31 | $46.30 Million | +16.38% |
| 2020-12-31 | $39.79 Million | -60.54% |
| 2019-12-31 | $100.83 Million | +29.40% |
| 2018-12-31 | $77.92 Million | -- |
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spe… Read more